This low binding propensity of ApoE2 for LDLR leads to impaired clearance of triglyceride-rich lipoprotein remnant particles, thereby contributing to the onset of type III hyperlipoproteinemia (Mahley, 1988; Phillips, 2014). Here, LDLR is linked to hyperlipoproteinemia type 3.